Centrum Medyczne Senior
Sopot 81-855
0 studies enrolling now · 5 studies all time
What they study most
Alzheimer's Disease, Alzheimer's Disease Dementia, Early Alzheimer's Disease, Early Alzheimer´s Disease, Mild Cognitive Impairment Due to Alzheimer's Disease
Studies at this site
- A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE) — Completed
- A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — Running, not enrolling
- A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) — Completed
- A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 — Stopped early
- Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease — Stopped early